Drug repositioning of tranilast to sensitize a cancer therapy by targeting cancer‐associated fibroblast
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug repositioning of tranilast to sensitize a cancer therapy by targeting cancer‐associated fibroblast
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-07-25
DOI
10.1111/cas.15502
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug repositioning in cancer: The current situation in Japan
- (2020) Takaaki Masuda et al. CANCER SCIENCE
- Clinical safety and efficacy of neoadjuvant combination chemotherapy of tranilast in advanced esophageal squamous cell carcinoma
- (2020) Atsushi Shiozaki et al. MEDICINE
- Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer
- (2019) Qinglei Gao et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The Tumor Microenvironment Innately Modulates Cancer Progression
- (2019) Dominique C. Hinshaw et al. CANCER RESEARCH
- IL-6 mediates cross-talk between activated fibroblasts and tumor cells in the tumor microenvironment
- (2018) Tatiana A Karakasheva et al. CANCER RESEARCH
- Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance
- (2018) Helena A. Yu et al. CLINICAL CANCER RESEARCH
- Tranilast inhibits interleukin-33 production by macrophages
- (2018) Sachiko Hiraide et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilast
- (2017) Hiroto Saito et al. Gastric Cancer
- Esophageal cancer stem cells are suppressed by tranilast, a TRPV2 channel inhibitor
- (2017) Atsushi Shiozaki et al. JOURNAL OF GASTROENTEROLOGY
- JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non–Small Cell Lung Cancer
- (2017) Kazuhiko Shien et al. MOLECULAR CANCER THERAPEUTICS
- Tranilast: A review of its therapeutic applications
- (2015) Sara Darakhshan et al. PHARMACOLOGICAL RESEARCH
- Drug Resistance via Feedback Activation of Stat3 in Oncogene-Addicted Cancer Cells
- (2014) Ho-June Lee et al. CANCER CELL
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Cancer-associated fibroblasts induce epithelial–mesenchymal transition of breast cancer cells through paracrine TGF-β signalling
- (2013) Y Yu et al. BRITISH JOURNAL OF CANCER
- Analysis of Tumor Specimens at the Time of Acquired Resistance to EGFR-TKI Therapy in 155 Patients with EGFR-Mutant Lung Cancers
- (2013) H. A. Yu et al. CLINICAL CANCER RESEARCH
- Cancer-Associated Fibroblasts Drive the Progression of Metastasis through both Paracrine and Mechanical Pressure on Cancer Tissue
- (2012) G. S. Karagiannis et al. MOLECULAR CANCER RESEARCH
- New driver mutations in non-small-cell lung cancer
- (2011) William Pao et al. LANCET ONCOLOGY
- IL-6 promotes malignant growth of skin SCCs by regulating a network of autocrine and paracrine cytokines
- (2010) Wiltrud Lederle et al. INTERNATIONAL JOURNAL OF CANCER
- Breast Cancer Stem-Like Cells Are Inhibited by a Non-Toxic Aryl Hydrocarbon Receptor Agonist
- (2010) Gérald J. Prud'homme et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now